Get the Stockscreener App
0.80
0.48%
0.0038
Pre-market:
.80
Predictive Oncology Inc stock is traded at $0.80, with a volume of 119.03K.
It is up +0.48% in the last 24 hours and down -9.09% over the past month.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
See More
Previous Close:
$0.7962
Open:
$0.8
24h Volume:
119.03K
Relative Volume:
0.72
Market Cap:
$7.15M
Revenue:
$1.52M
Net Income/Loss:
$-13.97M
P/E Ratio:
-0.2623
EPS:
-3.05
Net Cash Flow:
$-13.29M
1W Performance:
+2.37%
1M Performance:
-9.09%
6M Performance:
-45.58%
1Y Performance:
-25.23%
1-Day Range:
$0.79
$0.82
1-Week Range:
$0.75
$0.82
52-Week Range:
$0.55
$3.06
Predictive Oncology Inc Stock (POAI) Company Profile
Name
Predictive Oncology Inc
Sector
Industry
Phone
412-432-1500
Address
91 43RD STREET, PITTSBURGH, MN
Compare POAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
POAI
Predictive Oncology Inc
|
0.80 | 7.46M | 1.52M | -13.97M | -13.29M | -3.05 |
|
ISRG
Intuitive Surgical Inc
|
488.61 | 179.91B | 9.15B | 2.61B | 1.75B | 7.17 |
|
BDX
Becton Dickinson Co
|
183.63 | 52.33B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
91.90 | 45.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
273.50 | 40.08B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
279.10 | 16.33B | 2.90B | 467.20M | 306.90M | 6.37 |
Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Initiated | H.C. Wainwright | Buy |
Predictive Oncology Inc Stock (POAI) Latest News
What analysts say about Predictive Oncology Inc. stockFast-track wealth growth - Autocar Professional
What drives Predictive Oncology Inc. stock priceExtraordinary performance - Autocar Professional
Predictive Oncology Granted Nasdaq Compliance Extension - TipRanks
Predictive Oncology Inc. Stock Analysis and ForecastHigh-octane investment gains - jammulinksnews.com
Is Predictive Oncology Inc. a good long term investmentGame-changing capital returns - jammulinksnews.com
Predictive Oncology (POAI) Announces Stock Offering by Existing Holders - GuruFocus
Predictive Oncology to Sell 1.92M Shares, Potentially Raising Capital and Enhancing Financial Flexibility. - AInvest
Predictive Oncology (POAI) Announces Plan to Offer 1.92M Shares - GuruFocus
How Predictive Oncology Inc. stock performs during market volatilityFree Market Sentiment Analysis - Newser
Predictive Oncology Sells Eagan Business to DeRoyal - TipRanks
why predictive oncology inc. stock attracts strong analyst attentionRapid Gain Targets - Newser
Why Predictive Oncology Inc. stock attracts strong analyst attentionPortfolio Boosting Stock Alerts - Newser
What makes Predictive Oncology Inc. stock price move sharplyFree Investment Community - Newser
Predictive Oncology secures $10 million funding agreement for growth By Investing.com - Investing.com Nigeria
Predictive Oncology secures $10 million funding agreement for growth - Investing.com Australia
Predictive Oncology Inc. Secures $10 Million Securities Purchase Agreement to Support Growth Initiatives and ChemoFx Expansion - Quiver Quantitative
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities - GlobeNewswire
Predictive Oncology Lands $10M Deal to Scale AI-Powered Cancer Testing Platform Across US and Europe - Stock Titan
Predictive Oncology receives Nasdaq notice for minimum bid price noncompliance - Investing.com Australia
Predictive Oncology Finalizes Stock Exchange Purchase Agreement - The Globe and Mail
Predictive Oncology Completes Stock Exchange Purchase Agreement with Accredited Investor - AInvest
Predictive Oncology secures $10 million equity purchase agreement By Investing.com - Investing.com South Africa
Predictive Oncology enters into $10M share purchase agreement with New Jersey-based firm - The Business Journals
Predictive Oncology secures $10 million equity purchase agreement - Investing.com
Predictive Oncology stock falls after announcing $10M equity purchase deal - Investing.com Australia
Predictive Oncology Enters Standby Equity Purchase Agreement With YA II PN - Nasdaq
Predictive Oncology Inc Stock (POAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.63%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):